EHMT2 and neuroblastoma: Transcriptional analyses indicated that G9a/Ehmt2 gene levels were higher in tumors belonging to the St4 International Neuroblastoma Staging System (INSS) stage compared to patients with St3 and St4s tumors, which can exhibit a better prognosis (Figure 1A).